Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 May 5;4(8):1158–1171. doi: 10.1158/1940-6207.CAPR-10-0006

Figure 4.

Figure 4

(a) shows photographs of blank implants and of curcumin implants. (b) In Vitro release of curcumin from a 2-cm implant (3.4 mm diameter; 200 mg) with 10% curcumin load (n=3). (c) In vivo release of curcumin from a 2-cm implant formulated either with 10% or 20% curcumin load (n=3). Implants were grafted subcutaneously at the back of Sprague-Dawley rats and were recovered at the time of euthanasia at indicated times to measure the residual curcumin content. Cumulative release was calculated by subtracting residual amount at each interval from initial amount of drug present in implants (reproduced with permission from data published by Bansal et al.) (10).